NCT07399912Enrolling by invitation
Engaging Home-monitored Assessment to Navigate Clinical Decision-making
Engaging Home-monitored Assessment to Navigate Clinical Decision-making -The ENHANCe Study
Source: ClinicalTrials.gov · Last updated 10 Feb 2026
Brief summary (registry, in English)
This study is testing a new app called ENHANCe, which is designed to help family doctors manage patients with high blood pressure using readings taken at home.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 116 (estimated)
- First submitted
- 28 Dec 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 1 Oct 2026
- Lead sponsor
- SingHealth Polyclinics
- Diseases
- High blood pressure
- NCT number
- NCT07399912
What you commit to
- Study type: Interventional
- Planned participants: 116
- From 1 Oct 2025 to the primary completion date, 1 Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Documentation of dementia diagnosis in EMR
Other
- Audio or visual impairments
- Hypertensive urgency or emergency
Who the study is looking for
- For primary care physicians:
- PCPs aged 21 years and above.
- Involved in the clinical management of patients with hypertension in the past six months.
- For patients:
- Patients aged 21 years and above
- Documentation of hypertension diagnosis in EMR
- Owns an HBP monitoring device
Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SingHealth Polyclinics Coordinator of this site? Confirm its status | Singapore | Singapore | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.